.Attribute Medication, Published online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint asks for incorporation of people along with MASLD and also measurement of liver results in cardio-- kidney-- metabolic tests, when records recommend mechanistically conceivable benefits and also clinical safety-- and also outlines points to consider for trial design and regulatory commendation.